Zobrazeno 1 - 10
of 12
pro vyhledávání: '"J E Obradovich"'
Autor:
R. Walshaw, Rebecca C. Smedley, J. M. Ottnod, Joe G. Hauptman, J. E. Obradovich, Matti Kiupel
Publikováno v:
Veterinary and Comparative Oncology. 11:219-229
Oral malignant melanoma (OMM) in the dog is often locally aggressive with a high metastatic potential and there are few treatment options that have been demonstrated to improve outcome of this disease. The purpose of this study was to determine wheth
Autor:
J. E. Obradovich, Richard A Lecouteur, Andrew W. Bollen, Robert Higgins, Beverly K. Sturges, Karen M. Vernau
Publikováno v:
Veterinary Pathology. 38:620-627
Although pure granular cell tumors have been reported in various sites in the dog, only one tumor has been reported in the central nervous system. Two dogs presented with neurologic signs had brain lesions detected by magnetic resonance imaging in th
Publikováno v:
Veterinary and comparative oncology. 11(3)
Oral malignant melanoma (OMM) in the dog is often locally aggressive with a high metastatic potential and there are few treatment options that have been demonstrated to improve outcome of this disease. The purpose of this study was to determine wheth
Publikováno v:
Journal of Veterinary Internal Medicine. 6:96-101
Case records of 11 dogs with histologically confirmed carotid body tumors were reviewed. Surgical excision had been attempted in ten dogs with carotid body tumors, and one dog had been euthanatized at diagnosis. There were no intraoperative deaths bu
Publikováno v:
Clinical cancer research : an official journal of the American Association for Cancer Research. 4(6)
A cutaneous reaction termed palmar-plantar erythrodysesthesia (PPES) or hand-foot syndrome can be dose limiting for Doxil, a doxorubicin containing pegylated (Stealth) liposome. The objective of this study was to determine the ability of concomitant
Autor:
D M, Vail, W C, Kisseberth, J E, Obradovich, F M, Moore, C A, London, E G, MacEwen, M A, Ritter
Publikováno v:
Experimental hematology. 24(7)
The predictive potential of several proliferation indices for therapeutic outcome was investigated in 55 dogs with spontaneously occurring non-Hodgkin's lymphoma (NHL). Indices included potential doubling time (Tpot), argyrophilic nucleolar organizer
Autor:
D M, Vail, E G, MacEwen, I D, Kurzman, R R, Dubielzig, S C, Helfand, W C, Kisseberth, C A, London, J E, Obradovich, B R, Madewell, C O, Rodriguez
Publikováno v:
Clinical cancer research : an official journal of the American Association for Cancer Research. 1(10)
Canine splenic hemangiosarcoma (HSA) is a spontaneous tumor with high metastatic potential. Despite surgical excision, most dogs die within 2 months of diagnosis as a result of widespread visceral metastasis. This study was designed to determine the
Autor:
W C Kisseberth, Janean Fidel, Evan T. Keller, B. Kitchell, J E Obradovich, R C Rosenthal, Ilene D. Kurzman, Stuart C. Helfand, David M. Vail, E G MacEwen, Carlos O. Rodriguez, C L London, Leslie E. Fox, Bruce R. Madewell, S. Susaneck, M. Rosenberg
Publikováno v:
Journal of drug targeting. 2(5)
Targeted delivery of macrophage activating agents is an attractive approach to treat micrometastatic disease. Liposome-encapsulated muramyl tripeptide phosphatidylethanolamine (L-MTP-PE) is a potent activator of monocytes/macrophages in humans, mice,
Autor:
G K, Ogilvie, A S, Moore, J E, Obradovich, R E, Elmslie, D M, Vail, R C, Straw, M D, Salmon, M K, Klein, S W, Atwater, P E, Ciekot
Publikováno v:
Journal of the American Veterinary Medical Association. 202(11)
Eighty-seven cats with histologically confirmed malignant tumors were used in a prospective study to determine the toxicity of mitoxantrone, a dihydroxyquinone derivative of anthracene, which was administered at 21-day intervals at dosages ranging fr
Autor:
G K, Ogilvie, J E, Obradovich, R E, Elmslie, D M, Vail, A S, Moore, C R, Curtis, R C, Straw, K, Dickinson, M F, Cooper, S J, Withrow
Publikováno v:
Journal of the American Veterinary Medical Association. 198(9)
One hundred twenty-nine dogs with histologically confirmed malignant tumors were used in a prospective study to determine the toxicity of the new dihydroxyquinone derivative of anthracene, mitoxantrone, which was administered IV at 21-day intervals a